PYC Therapeutics Limited (ASX:PYC)
1.255
-0.020 (-1.57%)
Jul 31, 2025, 12:38 PM AEST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 743.66 million as of July 30, 2025. Its market cap has increased by 22.60% in one year.
Market Cap
743.66M
Enterprise Value
695.88M
Revenue
24.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.26
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 743.66M, an increase of 2,551.69%. That is a compound annual growth rate of 17.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 30, 2025 | 743.66M | 20.74% |
Dec 31, 2024 | 615.92M | 50.00% |
Dec 29, 2023 | 410.62M | 87.08% |
Dec 30, 2022 | 219.48M | -48.89% |
Dec 31, 2021 | 429.43M | -8.19% |
Dec 31, 2020 | 467.71M | 157.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 131.02B |
Pro Medicus | 33.52B |
Cochlear | 20.46B |
Sonic Healthcare | 13.95B |
Ramsay Health Care | 8.87B |
Telix Pharmaceuticals | 7.19B |
Ansell | 4.47B |
Mesoblast | 3.19B |